Australians want cheaper medicines quicker

20 May 2019 - Just last week, an 18-year-old woman with a rare cancer was staring down the barrel of ...

Read more →

Celgene Corporation announces Pomalyst granted breakthrough therapy designation from FDA for HIV positive and negative Kaposi sarcoma

13 May 2019 - Celgene plans to submit sNDA by end of 2019. ...

Read more →

Novartis pitches discounts on pricey gene therapy for deadly muscle disorder

11 May 2019 - Novartis is offering price discounts in negotiations with U.S. health insurers on its gene therapy for spinal ...

Read more →

Japan health ministry orders Ono Pharmaceutical to add warning to Opdivo cancer drug after death

10 May 2019 - The health ministry said Thursday that a patient taking the cancer drug Opdivo has died and ...

Read more →

Congress should revive the Office of Technology Assessment

13 May 2019 - In recent decades, the U.S. economy and society have been propelled forward by a boom in science ...

Read more →

HTA frameworks for RA therapies need improvement, researchers say

13 May 2019 - Cost-effectiveness models for the treatment of rheumatoid arthritis first emerged in the early 2000s when highly effective ...

Read more →

Australia's GBMA launches hub for biosimilar education

13 May 2019 - In 2018, the Generic Biosimilar Medicines Association was awarded the Biosimilar Education Grant by the Australian government ...

Read more →

New cancer drugs approved for NHS use in Scotland

13 May 2019 - The Scottish Medicines Consortium accepted the use of new medicines to treat patients with breast and skin ...

Read more →

House Budget Committee announces hearing on single payer health care

10 May 2019 - The House Budget Committee on Friday announced that it will hold a hearing on single-payer health ...

Read more →

SMC - May 2019 decisions

13 May 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →

Considerations in demonstrating interchangeability with a reference product guidance for industry

9 May 2019 - This guidance is intended to assist sponsors in demonstrating that a proposed therapeutic protein product is interchangeable ...

Read more →

Safety, efficacy, and quality remain top priorities as we continue our work to expand access to cost-saving generic drugs for the American public

13 May 2019 - Millions of Americans have difficulty paying for their prescription medications. ...

Read more →

Two words to help Ned Sharpless revolutionise clinical trials: data standards

13 May 2019 - In the classic 1967 film “The Graduate,” young Benjamin Braddock was given one word of advice ...

Read more →

Grandstanding, not real change: why drug prices in TV ads will be confusing and irrelevant

13 May 2019 - In a fit of hubris, President Trump believes he is making drug makers “come clean” by ...

Read more →

The UK’s new medicines pricing deal – opportunities and risks for pharma

10 May 2019 - January 2019 saw the introduction of the new Voluntary Scheme for Branded Medicines Pricing and Access  ...

Read more →

MPs call for 'life-changing' Kuvan to be made affordable

11 May 2019 - A number of MPs are calling on a drug company to make a "life-changing" treatment affordable ...

Read more →